#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13234	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2172	606.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1541	1541	C	770	C	736	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13234	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2172	606.2	0	HET	.	.	.	C207T,G	.	207	207	C	564	564	C	707	C,T,G	540,129,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13234	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2172	606.2	0	HET	.	.	.	C451T	.	451	451	C	808	808	C	757	C,T	544,172	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24596	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3553	689.7	0	.	n	.	0	T695C	SNP	695	695	T	1010	1010	C	781	C	740	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24596	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3553	689.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2286	2286	C	795	C	744	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24596	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3553	689.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2360	2360	A	771	A	737	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24596	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3553	689.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2912	2912	C	764	C,T	727,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24596	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3553	689.7	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1953	1953	A	798	A,G,T	601,159,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1824	folP	855	855	100.0	folP.l15.c4.ctg.1	1546	117.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1029	1031	AGC	184;187;187	A;G;C	177;179;175	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5046	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3370	149.0	1	SNP	p	S91F	1	.	.	271	273	TTC	566	568	TTC	186;184;185	T;T;C	179;178;178	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5046	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3370	149.0	1	SNP	p	G95N	0	.	.	283	285	GGC	578	580	GGC	176;175;182	G;G;C	169;167;173	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5046	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3370	149.0	1	SNP	p	D95G	1	.	.	283	285	GGC	578	580	GGC	176;175;182	G;G;C	169;167;173	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1532	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1419	107.5	1	SNP	p	G45D	0	.	.	133	135	GGC	588	590	GGC	181;177;176	G;G;C	173;169;167	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	768	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1065	71.7	0	.	n	.	0	A197.	DEL	197	197	A	649	649	A	189	A	181	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3094	171.9	1	SNP	p	D86N	0	.	.	256	258	GAC	698	700	GAC	225;225;227	G;A;C	210;211;217	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3094	171.9	1	SNP	p	R87I	0	.	.	259	261	CGT	701	703	CGT	229;225;225	C;G;T	219;210;210	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3094	171.9	1	SNP	p	S87R	1	.	.	259	261	CGT	701	703	CGT	229;225;225	C;G;T	219;210;210	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3094	171.9	1	SNP	p	R87W	0	.	.	259	261	CGT	701	703	CGT	229;225;225	C;G;T	219;210;210	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5342	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3094	171.9	1	SNP	p	S88P	0	.	.	262	264	TCC	704	706	TCC	225;227;228	T;C;C	211;216;215	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4010	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2652	150.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1492	1494	GGC	218;217;215	G;G;C	205;203;200	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1336	1338	GCC	195;194;195	G;C;C	184;184;185	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1339	1341	ATG	198;200;199	A;T;G	188;189;188	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1351	1353	ACC	197;197;198	A;C;C	187;188;189	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1351	1353	ACC	197;197;198	A;C;C	187;188;189	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1852	1854	ACC	223;220;220	A;C;C	205;205;206	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1906	1908	GCG	207;205;202	G,T;C;G	192,1;195;189	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1906	1908	GCG	207;205;202	G,T;C;G	192,1;195;189	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2029	2031	GGT	165;164;165	G;G;T	156;155;156	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2038	2040	AGC	163;163;162	A;G;C	148;148;147	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3530	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2630	133.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2056	2058	CCG	143;148;148	C,G;C,G;G	107,5;115,1;118	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5350	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3192	167.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1659	1661	CCG	218;217;215	C;C;G	197;203;195	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2494	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1812	137.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	571	571	C	179	C	168	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2432	porB1b	1038	1038	99.52	porB1b.l15.c17.ctg.1	1817	133.5	0	.	p	.	0	N214del	DEL	640	640	A	1011	1011	T	222	T	215	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2432	porB1b	1038	1038	99.52	porB1b.l15.c17.ctg.1	1817	133.5	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1123	1125	GAA	214;215;212	G;A;A	198;199;198	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2432	porB1b	1038	1038	99.52	porB1b.l15.c17.ctg.1	1817	133.5	0	.	p	.	0	G321S	NONSYN	961	963	GGC	1330	1332	AGC	197;196;197	A;G;C	190;189;190	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2432	porB1b	1038	1038	99.52	porB1b.l15.c17.ctg.1	1817	133.5	1	SNP	p	G120K	1	.	.	358	360	AAG	730	732	AAG	209;207;208	A;A;G	198;199;194	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2432	porB1b	1038	1038	99.52	porB1b.l15.c17.ctg.1	1817	133.5	1	SNP	p	A121N	1	.	.	361	363	AAC	733	735	AAC	207;207;207	A;A;C	195;196;196	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2432	porB1b	1038	1038	99.52	porB1b.l15.c17.ctg.1	1817	133.5	1	SNP	p	N121D	0	.	.	361	363	AAC	733	735	AAC	207;207;207	A;A;C	195;196;196	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9922	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4896	202.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1078	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1073	100.0	1	SNP	p	V57M	1	.	.	169	171	ATG	621	623	ATG	225;226;226	A;T;G	216;217;214	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
